Yantai Dongcheng Pharmaceutical Co Ltd
Yantai Dongcheng Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the manufacture and sale of biochemical APIs, finished dosage forms, nuclide drugs, and healthy products for cardiovascular, antitumor, urology, orthopedics, and other therapeutic areas. It offers heparin, chondroitin sulphate sodium and calcium, and glucosamine series products, as well as collagen, hyaluro… Read more
Yantai Dongcheng Pharmaceutical Co Ltd (002675) - Total Liabilities
Latest total liabilities as of September 2025: CN¥3.84 Billion CNY
Based on the latest financial reports, Yantai Dongcheng Pharmaceutical Co Ltd (002675) has total liabilities worth CN¥3.84 Billion CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Yantai Dongcheng Pharmaceutical Co Ltd - Total Liabilities Trend (2008–2024)
This chart illustrates how Yantai Dongcheng Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Yantai Dongcheng Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Yantai Dongcheng Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
A10 Network
NYSE:ATEN
|
USA | $418.27 Million |
|
Societatea Nationala de Transport Gaze Naturale Transgaz SA
RO:TGN
|
Romania | RON6.20 Billion |
|
Maze Therapeutics, Inc. Common Stock
NASDAQ:MAZE
|
USA | $42.62 Million |
|
CPFL Energia S.A
SA:CPFE3
|
Brazil | R$57.60 Billion |
|
Cetc Potevio Science&Technology Co Ltd
SHE:002544
|
China | CN¥5.55 Billion |
|
Beijing YanDong MicroElectronic Co. Ltd. A
SHG:688172
|
China | CN¥4.51 Billion |
|
TAL Education Group
NYSE:TAL
|
USA | $2.02 Billion |
|
Shenzhen Hopewind Elec Co Ltd
SHG:603063
|
China | CN¥4.03 Billion |
Liability Composition Analysis (2008–2024)
This chart breaks down Yantai Dongcheng Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.71 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.88 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.41 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Yantai Dongcheng Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Yantai Dongcheng Pharmaceutical Co Ltd (2008–2024)
The table below shows the annual total liabilities of Yantai Dongcheng Pharmaceutical Co Ltd from 2008 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥3.26 Billion | +21.46% |
| 2023-12-31 | CN¥2.69 Billion | -7.18% |
| 2022-12-31 | CN¥2.89 Billion | +9.96% |
| 2021-12-31 | CN¥2.63 Billion | +8.44% |
| 2020-12-31 | CN¥2.43 Billion | -3.52% |
| 2019-12-31 | CN¥2.52 Billion | +6.76% |
| 2018-12-31 | CN¥2.36 Billion | +18.76% |
| 2017-12-31 | CN¥1.98 Billion | +67.61% |
| 2016-12-31 | CN¥1.18 Billion | +279.54% |
| 2015-12-31 | CN¥311.94 Million | +49.21% |
| 2014-12-31 | CN¥209.06 Million | +64.39% |
| 2013-12-31 | CN¥127.18 Million | +74.59% |
| 2012-12-31 | CN¥72.84 Million | -50.38% |
| 2011-12-31 | CN¥146.82 Million | -12.68% |
| 2010-12-31 | CN¥168.14 Million | +32.88% |
| 2009-12-31 | CN¥126.53 Million | +9.32% |
| 2008-12-31 | CN¥115.74 Million | -- |